FDA NDC Directory · JSON-LD · Markdown

NAFCILLIN

NDC 0338-1019 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerBaxter Healthcare Corporation
Marketing categoryNew Drug Application (innovator) · App NDA050655
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsNAFCILLIN SODIUM (2 g/100mL)
Marketing started19891031
Package count1

External sources

Source: openFDA. Public-domain (CC0).